AAAAAA

   
Results: 1-19 |
Results: 19
IMMUNOLOCALIZATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) AND ITS RECEPTORS (FLT-1 AND KDR FLK-1) SHOW DISTINCT PATTERNS IN NORMAL KIDNEY/
Authors: WRIGHT BD KLASSEN T KEYT B HILLAN KJ RYAN AM CAIRNS B
Citation: Bd. Wright et al., IMMUNOLOCALIZATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) AND ITS RECEPTORS (FLT-1 AND KDR FLK-1) SHOW DISTINCT PATTERNS IN NORMAL KIDNEY/, The FASEB journal, 12(4), 1998, pp. 598-598
A SENSITIVE FLUOROMETRIC ENZYME-LINKED-IMMUNOSORBENT-ASSAY THAT MEASURES VASCULAR ENDOTHELIAL GROWTH FACTOR(165) IN HUMAN PLASMA
Authors: RODRIGUEZ CR FEI DT KEYT B BALY DL
Citation: Cr. Rodriguez et al., A SENSITIVE FLUOROMETRIC ENZYME-LINKED-IMMUNOSORBENT-ASSAY THAT MEASURES VASCULAR ENDOTHELIAL GROWTH FACTOR(165) IN HUMAN PLASMA, Journal of immunological methods, 219(1-2), 1998, pp. 45-55
INTRAVENOUS-INFUSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) SUBSTANTIALLY ATTENUATES ITS HEMODYNAMIC-EFFECTS
Authors: YANG RH BUNTING S KO A KEYT B FERRARA N JIN H
Citation: Rh. Yang et al., INTRAVENOUS-INFUSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) SUBSTANTIALLY ATTENUATES ITS HEMODYNAMIC-EFFECTS, The FASEB journal, 11(3), 1997, pp. 2893-2893
NEUTRALIZING ANTI-VEGF MONOCLONAL-ANTIBODIES ARE SPECIFIC FOR RECEPTOR EPITOPES (KDR OR FLT-1) OR THE HEPARIN-BINDING DOMAIN
Authors: NGUYEN H BERLEAU L PARK J KIM J FERRARA N KEYT B
Citation: H. Nguyen et al., NEUTRALIZING ANTI-VEGF MONOCLONAL-ANTIBODIES ARE SPECIFIC FOR RECEPTOR EPITOPES (KDR OR FLT-1) OR THE HEPARIN-BINDING DOMAIN, Thrombosis and haemostasis, 1997, pp. 643-643
INHIBITION OF FIBRIN CLOT AND THROMBUS LYSIS BY ALPHA(2)-ANTIPLASMIN
Authors: ROBBIE LA KEYT B BENNETT B BOOTH NA
Citation: La. Robbie et al., INHIBITION OF FIBRIN CLOT AND THROMBUS LYSIS BY ALPHA(2)-ANTIPLASMIN, Thrombosis and haemostasis, 1997, pp. 1466-1466
EFFECTS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ON HEMODYNAMICS AND CARDIAC-PERFORMANCE
Authors: YANG RH THOMAS GR BUNTING S KO A FERRARA N KEYT B ROSS J JIN HK
Citation: Rh. Yang et al., EFFECTS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR ON HEMODYNAMICS AND CARDIAC-PERFORMANCE, Journal of cardiovascular pharmacology, 27(6), 1996, pp. 838-844
THE IN-VIVO BIOACTIVITY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR IS INDEPENDENT OF N-LINKED GLYCOSYLATION
Authors: WALTER DH HINK U ASAHARA T VANBELLE E HOROWITZ J TSURUMI Y VANDLEN R HEINSOHN H KEYT B FERRARA N SYMES JF ISNER JM
Citation: Dh. Walter et al., THE IN-VIVO BIOACTIVITY OF VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR IS INDEPENDENT OF N-LINKED GLYCOSYLATION, Laboratory investigation, 74(2), 1996, pp. 546-556
VEGF IMPROVES MYOCARDIAL BLOOD-FLOW BUT PRODUCES EDRF-MEDIATED HYPOTENSION IN PORCINE HEARTS
Authors: HARIAWALA MD HOROWITZ JR ESAKOF D SHERIFF DD WALTER D KEYT B ISNER JM SYMES JF
Citation: Md. Hariawala et al., VEGF IMPROVES MYOCARDIAL BLOOD-FLOW BUT PRODUCES EDRF-MEDIATED HYPOTENSION IN PORCINE HEARTS, The Journal of surgical research, 63(1), 1996, pp. 77-82
HYPOXIA-INDUCED PARACRINE REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR EXPRESSION
Authors: BROGI E SCHATTEMAN G WU T KIM EA VARTICOVSKI L KEYT B ISNER JM
Citation: E. Brogi et al., HYPOXIA-INDUCED PARACRINE REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR EXPRESSION, The Journal of clinical investigation, 97(2), 1996, pp. 469-476
PAI-1-RESISTANT T-PA - LOW-DOSES PREVENT FIBRIN DEPOSITION IN RABBITSWITH INCREASED PAI-1 ACTIVITY
Authors: KRISHNAMURTI C KEYT B MAGLASANG P ALVING BM
Citation: C. Krishnamurti et al., PAI-1-RESISTANT T-PA - LOW-DOSES PREVENT FIBRIN DEPOSITION IN RABBITSWITH INCREASED PAI-1 ACTIVITY, Blood, 87(1), 1996, pp. 14-19
HYPOXIA-INDUCED PARACRINE REGULATION OF VEGF RECEPTOR EXPRESSION
Authors: BROGI E SCHATTEMAN G WU TG KIM EA VARTICOVSKI L KEYT B ISNER JM
Citation: E. Brogi et al., HYPOXIA-INDUCED PARACRINE REGULATION OF VEGF RECEPTOR EXPRESSION, Circulation, 92(8), 1995, pp. 531-531
HEMODYNAMIC-EFFECTS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN CONSCIOUS RATS
Authors: YANG RH BUNTING S KO A KEYT B JIN HK
Citation: Rh. Yang et al., HEMODYNAMIC-EFFECTS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN CONSCIOUS RATS, Circulation, 92(8), 1995, pp. 2712-2712
IN-VIVO ADMINISTRATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IS ASSOCIATED WITH EDRF-DEPENDENT DECREASE IN SYSTEMIC HYPOTENSION IN PORCINE AND RABBIT
Authors: HOROWITZ J HARIAWALA M SHERIFF DD KEYT B
Citation: J. Horowitz et al., IN-VIVO ADMINISTRATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IS ASSOCIATED WITH EDRF-DEPENDENT DECREASE IN SYSTEMIC HYPOTENSION IN PORCINE AND RABBIT, Circulation, 92(8), 1995, pp. 3024-3024
A NEW VARIANT OF TISSUE-PLASMINOGEN ACTIVATOR WITH ENHANCED EFFICACY AND LOWER INCIDENCE OF BLEEDING WHEN COMPARED TO RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR (ACTIVASE)
Authors: BENEDICT CR REFINO C KEYT B PAONI N TODD J PATER C BADILLO J THOMAS R BENNETT W
Citation: Cr. Benedict et al., A NEW VARIANT OF TISSUE-PLASMINOGEN ACTIVATOR WITH ENHANCED EFFICACY AND LOWER INCIDENCE OF BLEEDING WHEN COMPARED TO RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR (ACTIVASE), Journal of the American College of Cardiology, 1994, pp. 10000314-10000314
COMPARATIVE THROMBOLYTIC PROPERTIES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND OF A PLASMINOGEN-ACTIVATOR INHIBITOR-1-RESISTANT GLYCOSYLATIONVARIANT, IN A COMBINED ARTERIAL AND VENOUS THROMBOSIS MODEL IN THE DOG
Authors: COLLEN D STASSEN JM YASUDA T REFINO C PAONI N KEYT B ROSKAMS T GUERRERO JL LIJNEN HR GOLD HK BENNETT WF
Citation: D. Collen et al., COMPARATIVE THROMBOLYTIC PROPERTIES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND OF A PLASMINOGEN-ACTIVATOR INHIBITOR-1-RESISTANT GLYCOSYLATIONVARIANT, IN A COMBINED ARTERIAL AND VENOUS THROMBOSIS MODEL IN THE DOG, Thrombosis and haemostasis, 72(1), 1994, pp. 98-104
ELEVATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) IN EYES OF PATIENTS WITH ACTIVE PROLIFERATIVE DIABETIC-RETINOPATHY
Authors: AIELLO LP AVERY R ARRIGG P SHAH S KEYT B FERRARA N AIELLO LM
Citation: Lp. Aiello et al., ELEVATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) IN EYES OF PATIENTS WITH ACTIVE PROLIFERATIVE DIABETIC-RETINOPATHY, Diabetes, 43, 1994, pp. 10000148-10000148
EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES AGAINST TISSUE-TYPE PLASMINOGEN-ACTIVATOR USING ALANINE SCAN VARIANTS - FUNCTIONAL-CHARACTERIZATION OF DEFINED ANTIGENIC DETERMINANTS
Authors: NGUYEN H ARCILA P CLARK K FENDLY B BENNETT W KEYT B
Citation: H. Nguyen et al., EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES AGAINST TISSUE-TYPE PLASMINOGEN-ACTIVATOR USING ALANINE SCAN VARIANTS - FUNCTIONAL-CHARACTERIZATION OF DEFINED ANTIGENIC DETERMINANTS, Thrombosis and haemostasis, 69(6), 1993, pp. 826-826
PHARMACOKINETICS AND PHARMACODYNAMICS OF TPA VARIANTS IN RABBITS
Authors: BERLEAU L NGUYEN H MODI N BENNETT W KEYT B
Citation: L. Berleau et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TPA VARIANTS IN RABBITS, Thrombosis and haemostasis, 69(6), 1993, pp. 840-840
SUBTLE ALTERATIONS OF TISSUE-PLASMINOGEN ACTIVATOR YIELD REDUCED PLASMA-CLEARANCE WITH CONSERVED FIBRINOLYTIC-ACTIVITY - A NOVEL FIBRIN SPECIFIC TPA VARIANT WITH 6 FOLD INCREASED POTENCY
Authors: KEYT B BERLEAU L NGUYEN H REFINO C PAONI N BENNETT W
Citation: B. Keyt et al., SUBTLE ALTERATIONS OF TISSUE-PLASMINOGEN ACTIVATOR YIELD REDUCED PLASMA-CLEARANCE WITH CONSERVED FIBRINOLYTIC-ACTIVITY - A NOVEL FIBRIN SPECIFIC TPA VARIANT WITH 6 FOLD INCREASED POTENCY, Thrombosis and haemostasis, 69(6), 1993, pp. 992-992
Risultati: 1-19 |